92 related articles for article (PubMed ID: 4396890)
1. Mass spectrometry of fluorinated corticosteroidal 1,4-dien-3-ones of the British Pharmacopoeia.
Lodge BA; Toft P
J Pharm Pharmacol; 1971 Mar; 23(3):196-9. PubMed ID: 4396890
[No Abstract] [Full Text] [Related]
2. THE USE AND ABUSE OF TOPICAL STEROID THERAPY.
WRONG NM
Can Med Assoc J; 1965 Jun; 92(25):1309-10. PubMed ID: 14291460
[No Abstract] [Full Text] [Related]
3. BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID.
WILLIAMS DI; WILKINSON DS; OVERTON J; MILNE JA; MCKENNA WB; LYELL A; CHURCH R
Lancet; 1964 May; 1(7344):1177-9. PubMed ID: 14132653
[No Abstract] [Full Text] [Related]
4. [PHARMACOLOGY OF SYNTHETIC CORTICAL STEROIDS OF ANTIINFLAMMATORY ACTION].
GIJON JR; RODRIGUEZMURCIA C; ALIADIAZ M
An Real Acad Farm; 1963; 29():361-90. PubMed ID: 14122037
[No Abstract] [Full Text] [Related]
5. Prednacinolone, a new anti-inflammatory steroid. 1. Chemical and physical properties.
Mantica L; Ciceri R; Assagne JP; Mascitelli-Coriandoli E
Arzneimittelforschung; 1970 Jan; 20(1):109-10. PubMed ID: 5467433
[No Abstract] [Full Text] [Related]
6. The croton oil inflammation suppression assay as a measure of topical corticosteroid potency.
Ortega E; Rodriguez C; Burdick KH; Place VA; Gonzales L
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):95-7. PubMed ID: 5291641
[No Abstract] [Full Text] [Related]
7. NMR analysis of synthetic corticosteroids of the 1,4-dien-3-one type.
Avdovich HW; Hanbury P; Lodge BA
J Pharm Sci; 1970 Aug; 59(8):1164-7. PubMed ID: 5457335
[No Abstract] [Full Text] [Related]
8. [Pharmacology of dermatocorticoids (2. Continuation)].
Weirich EG
Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
[No Abstract] [Full Text] [Related]
9. [A double-blind clinical trial of fluocinonide and betamethasone valerate in psoriasis].
Feuerman E
Harefuah; 1974 Jul; 87(2):59-60. PubMed ID: 4605470
[No Abstract] [Full Text] [Related]
10. Determination of betamethasone and triamcinolone acetonide by GC-NCI-MS in excreta of treated animals and development of a fast oxidation procedure for derivatisation of corticosteroids.
Courtheyn D; Vercammen J; Logghe M; Seghers H; De Wasch K; De Brabander H
Analyst; 1998 Dec; 123(12):2409-14. PubMed ID: 10435270
[TBL] [Abstract][Full Text] [Related]
11. A COMPARISON OF FLUOCINOLONE AND TRIAMCINOLONE ACETONIDES.
CHALMERS D; MORLEY WN
Br J Dermatol; 1963 Jul; 75():278-9. PubMed ID: 14046147
[No Abstract] [Full Text] [Related]
12. Inhibition of contact sensitivity in the mouse by topical application of corticosteroids.
Evans DP; Hossack M; Thomson DS
Br J Pharmacol; 1971 Oct; 43(2):403-8. PubMed ID: 5158205
[TBL] [Abstract][Full Text] [Related]
13. Antiinflammatory activity and thymolytic effect of a new corticosteroid ester (I.S.F. 2073) by topical application.
Banfi S; Cornelli U; Carpi C
Curr Ther Res Clin Exp; 1976 Jan; 19(1):126-32. PubMed ID: 812657
[No Abstract] [Full Text] [Related]
14. Evaluation of the efficacy of topical corticosteroids.
Zaynoun ST; Kurban AK
Br J Dermatol; 1974 Jan; 90(1):85-90. PubMed ID: 4811838
[No Abstract] [Full Text] [Related]
15. Betamethasone valerate ointment (Valisone).
Med Lett Drugs Ther; 1969 Sep; 11(18):76. PubMed ID: 5820569
[No Abstract] [Full Text] [Related]
16. The evaluation of several topical corticosteroid preparations in the blanching test.
Coldman MF; Lockerbie L; Laws EA
Br J Dermatol; 1971 Oct; 85(4):381-7. PubMed ID: 5125641
[No Abstract] [Full Text] [Related]
17. Efficacy of two fluorinated topical steroids in the treatment of common eczemas, on a once a day treatment schedule.
Neumann L
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):74-6. PubMed ID: 5291637
[No Abstract] [Full Text] [Related]
18. [Penetration kinetics of topical steroids].
Tronnier H
Arch Klin Exp Dermatol; 1970; 237(3):769-73. PubMed ID: 5523569
[No Abstract] [Full Text] [Related]
19. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.
Ciulla TA; Harris A; McIntyre N; Jonescu-Cuypers C
Expert Opin Pharmacother; 2014 May; 15(7):953-9. PubMed ID: 24661081
[TBL] [Abstract][Full Text] [Related]
20. [Vasoconstrictive activity of a new anti-inflammatory agent in man: difluprednate].
Barbier A; Girard J; Lafille C; Hincky M
Therapie; 1978; 33(5):607-14. PubMed ID: 741421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
